Futerman AH - Search Results

1

Absence of infiltrating peripheral myeloid cells in the brains of mouse models of lysosomal storage disorders.

Cho SM, Vardi A, Platt N, Futerman AH. Cho SM, et al. Among authors: futerman ah. J Neurochem. 2019 Mar;148(5):625-638. doi: 10.1111/jnc.14483. Epub 2018 Aug 9. J Neurochem. 2019. PMID: 29900534 Free article.

2

Phospholipid synthesis is decreased in neuronal tissue in a mouse model of Sandhoff disease.

Buccoliero R, Bodennec J, Van Echten-Deckert G, Sandhoff K, Futerman AH. Buccoliero R, et al. Among authors: futerman ah. J Neurochem. 2004 Jul;90(1):80-8. doi: 10.1111/j.1471-4159.2004.02457.x. J Neurochem. 2004. PMID: 15198669 Free article.

3

The cell biology of lysosomal storage disorders.

Futerman AH, van Meer G. Futerman AH, et al. Nat Rev Mol Cell Biol. 2004 Jul;5(7):554-65. doi: 10.1038/nrm1423. Nat Rev Mol Cell Biol. 2004. PMID: 15232573 Review. No abstract available.

4

Defective calcium homeostasis in the cerebellum in a mouse model of Niemann-Pick A disease.

Ginzburg L, Futerman AH. Ginzburg L, et al. Among authors: futerman ah. J Neurochem. 2005 Dec;95(6):1619-28. doi: 10.1111/j.1471-4159.2005.03534.x. Epub 2005 Nov 8. J Neurochem. 2005. PMID: 16277603 Free article.

5

An exposed carboxyl group on sialic acid is essential for gangliosides to inhibit calcium uptake via the sarco/endoplasmic reticulum Ca2+-ATPase: relevance to gangliosidoses.

Ginzburg L, Li SC, Li YT, Futerman AH. Ginzburg L, et al. Among authors: futerman ah. J Neurochem. 2008 Jan;104(1):140-6. doi: 10.1111/j.1471-4159.2007.04983.x. J Neurochem. 2008. PMID: 18173730 Free article.

6

Common and uncommon pathogenic cascades in lysosomal storage diseases.

Vitner EB, Platt FM, Futerman AH. Vitner EB, et al. Among authors: futerman ah. J Biol Chem. 2010 Jul 2;285(27):20423-7. doi: 10.1074/jbc.R110.134452. Epub 2010 Apr 29. J Biol Chem. 2010. PMID: 20430897 Free PMC article. Review.

7

Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond.

Shachar T, Lo Bianco C, Recchia A, Wiessner C, Raas-Rothschild A, Futerman AH. Shachar T, et al. Among authors: futerman ah. Mov Disord. 2011 Aug 1;26(9):1593-604. doi: 10.1002/mds.23774. Epub 2011 May 26. Mov Disord. 2011. PMID: 21618611 Review.

8

Lysosomal storage disorders: old diseases, present and future challenges.

Klein AD, Futerman AH. Klein AD, et al. Among authors: futerman ah. Pediatr Endocrinol Rev. 2013 Nov;11 Suppl 1:59-63. Pediatr Endocrinol Rev. 2013. PMID: 24380123 Review.

9

Emerging therapeutic targets for Gaucher disease.

Vitner EB, Vardi A, Cox TM, Futerman AH. Vitner EB, et al. Among authors: futerman ah. Expert Opin Ther Targets. 2015 Mar;19(3):321-34. doi: 10.1517/14728222.2014.981530. Epub 2014 Nov 21. Expert Opin Ther Targets. 2015. PMID: 25416676 Review.

10

Delineating pathological pathways in a chemically induced mouse model of Gaucher disease.

Vardi A, Zigdon H, Meshcheriakova A, Klein AD, Yaacobi C, Eilam R, Kenwood BM, Rahim AA, Massaro G, Merrill AH Jr, Vitner EB, Futerman AH. Vardi A, et al. Among authors: futerman ah. J Pathol. 2016 Aug;239(4):496-509. doi: 10.1002/path.4751. Epub 2016 Jul 5. J Pathol. 2016. PMID: 27234572

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

269 results

Search Page